Table 2.

Cases of chronic hepatitis E virus infection in HIV-infected patients.

Case references	Gender	Age	CD4+ cells count	HEV anti IgM/IgG	HEV genotype	Duration of HEV viremia (months)	Outcome	Comment
Dalton et al., 2009	Male	48	<100	Pos/Pos	3a	24	Treatment initiation
Colson et al., 2009	Male	50	<100	Neg/Neg	3	12	Not reported
Jagjit, Singh et al., 2013	Male	45	54	Neg/Neg	3a	132	Treatment initiation
Kaba et al., 2011	Male	44	40	Pos/Neg	3f	10	Deceased	Diagnosis of chronic infection coincides with treatment time for non-Hodgkin’s lymphoma therapy
Kenfak-Foguena et al., 2011	Male	46	34	NT/Pos	3b	36	Spontaneous viral clearance	Viral clearance after CD4+ count increases
Kenfak-Foguena et al., 2011	Male	59	50	NT/Neg	3c	At least 6	Spontaneous viral clearance
Andersson et al., 2013	Male	42	37	Neg/Neg	3	36	Spontaneous viral clearance	Clearance after HAART initiation and CD4+ count restoration
Neukam et al., 2013	Male	47	<200	Pos/Neg	3	36	Treatment initiation
Neukam et al., 2013	Male	53	<200	Neg/Pos	3	60	Treatment initiation
Kuniholm et al., 2016	Female	–	<200	Neg/Neg	3a	36	Not reported
Ingiliz et al., 2016	Male	47	<200	Pos/Pos	3	48	Treatment initiation
Todesco et al., 2017	Male	59	<100	NT/NT	3i	48	Treatment initiation

CD4+, lymphocytes CD4+; HEV, hepatitis E virus; IgM, immunoglobulin M; IgG, immunoglobulin G; Pos, positive; Neg, negative; NT, non-tested.